Steven H. Holtzman - Articles and news items

Biogen Idec logo

Biogen Idec sells BENLYSTA royalty rights to DRI Capital managed fund

Industry news, News / 10 September 2012 / Biogen Idec

Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®…

Biogen Idec logo

Biogen Idec and Isis announce global collaboration for antisense program targeting myotonic dystrophy

Industry news, News / 29 June 2012 / Biogen Idec

Isis expands its rare disease franchise to include DM1…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+